Adjuvants: an essential component of neisseria vaccines
Fuente:
Redalyc
Guardado en:
| Autor principal: | |
|---|---|
| Formato: | Artículo científico |
| Lenguaje: | en |
| Publicado: |
Instituto Finlay
2009
|
| Materias: | |
| Acceso en línea: | |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| _version_ | 1876473251460284416 |
|---|---|
| author | Reinaldo Acevedo |
| author_facet | Reinaldo Acevedo |
| contents | Adjuvants: an essential component of neisseria vaccines Reinaldo Acevedo Belkis Romeu Judith del Campo Elizabeth Gonzáles Julio Balboa Caridad Zayas Maribel Cuello Osmir Cabrera Miriam Lastre Valerie A. Ferro Oliver Pérez Salud nano micro vaccine Adjuvant particle Adjuvants may be classified into delivery systems and immune potentiator or modulator molecules based on their mechanism of action. Neisseria vaccines containing traditional adjuvants such as aluminium salts have existed for long time, but meningitis caused by Neisseria meningitidis serogroups, particularly serogroup B, continues to be a global health problem. Novel strategies have applied in silico and recombinant technologies to develop "universal" antigens (e.g. proteins, peptides and plasmid DNA) for vaccines, but these antigens have been shown to be poorly immunogenic even when alum adjuvanted, implying a need for better vaccine design. In this work we review the use of natural, detoxified, or synthetic molecules in combination with antigens to activate the innate immune system and to modulate the adaptive immune responses. In the main, antigenic and imune potentiator signals are delivered using nano-, micro-particles, alum, or emulsions. The importance of interaction between adjuvants and antigens to activate and target dendritic cells, the bridge between the innate and adaptive immune systems, will be discussed. In addition, nasal vaccine strategies based on the development of mucosal adjuvants and Neisseria derivatives to eliminate the pathogen at the site of infection provide promising adjuvants effective not only against respiratory pathogens, but also against pathogens responsible for enteric and sexually transmitted diseases. 2009 artículo científico 1025-0298 https://www.redalyc.org/articulo.oa?id=203414610013 en http://www.redalyc.org/revista.oa?id=2034 VacciMonitor application/pdf Instituto Finlay VacciMonitor (Cuba) Num.2 Vol.18 |
| format | Artículo científico |
| id | redalyc_203414610013 |
| institution | Redalyc |
| language | en |
| publishDate | 2009 |
| publisher | Instituto Finlay |
| spellingShingle | Adjuvants: an essential component of neisseria vaccines Reinaldo Acevedo Salud nano micro vaccine Adjuvant particle Adjuvants: an essential component of neisseria vaccines Reinaldo Acevedo Belkis Romeu Judith del Campo Elizabeth Gonzáles Julio Balboa Caridad Zayas Maribel Cuello Osmir Cabrera Miriam Lastre Valerie A. Ferro Oliver Pérez Salud nano micro vaccine Adjuvant particle Adjuvants may be classified into delivery systems and immune potentiator or modulator molecules based on their mechanism of action. Neisseria vaccines containing traditional adjuvants such as aluminium salts have existed for long time, but meningitis caused by Neisseria meningitidis serogroups, particularly serogroup B, continues to be a global health problem. Novel strategies have applied in silico and recombinant technologies to develop "universal" antigens (e.g. proteins, peptides and plasmid DNA) for vaccines, but these antigens have been shown to be poorly immunogenic even when alum adjuvanted, implying a need for better vaccine design. In this work we review the use of natural, detoxified, or synthetic molecules in combination with antigens to activate the innate immune system and to modulate the adaptive immune responses. In the main, antigenic and imune potentiator signals are delivered using nano-, micro-particles, alum, or emulsions. The importance of interaction between adjuvants and antigens to activate and target dendritic cells, the bridge between the innate and adaptive immune systems, will be discussed. In addition, nasal vaccine strategies based on the development of mucosal adjuvants and Neisseria derivatives to eliminate the pathogen at the site of infection provide promising adjuvants effective not only against respiratory pathogens, but also against pathogens responsible for enteric and sexually transmitted diseases. 2009 artículo científico 1025-0298 https://www.redalyc.org/articulo.oa?id=203414610013 en http://www.redalyc.org/revista.oa?id=2034 VacciMonitor application/pdf Instituto Finlay VacciMonitor (Cuba) Num.2 Vol.18 |
| title | Adjuvants: an essential component of neisseria vaccines |
| topic | Salud nano micro vaccine Adjuvant particle |
| url | https://www.redalyc.org/articulo.oa?id=203414610013 |